Lisata Therapeutics (LSTA) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to -$19.3 million.
- Lisata Therapeutics' Enterprise Value rose 258.56% to -$19.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.3 million, marking a year-over-year increase of 258.56%. This contributed to the annual value of -$16.5 million for FY2024, which is 2794.24% up from last year.
- Latest data reveals that Lisata Therapeutics reported Enterprise Value of -$19.3 million as of Q3 2025, which was up 258.56% from -$17.1 million recorded in Q2 2025.
- Lisata Therapeutics' Enterprise Value's 5-year high stood at -$16.5 million during Q4 2024, with a 5-year trough of -$32.7 million in Q3 2023.
- Moreover, its 3-year median value for Enterprise Value was -$22.1 million (2024), whereas its average is -$22.9 million.
- As far as peak fluctuations go, Lisata Therapeutics' Enterprise Value tumbled by 1922.4% in 2024, and later surged by 4013.73% in 2025.
- Quarter analysis of 3 years shows Lisata Therapeutics' Enterprise Value stood at -$22.8 million in 2023, then grew by 27.94% to -$16.5 million in 2024, then fell by 16.94% to -$19.3 million in 2025.
- Its last three reported values are -$19.3 million in Q3 2025, -$17.1 million for Q2 2025, and -$20.5 million during Q1 2025.